prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.  it has been variably suggested that nonselective nsaids and cyclooxygenase (cox)-2 selective inhibitors aggravate or ameliorate clinical disease activity in patients with inflammatory bowel disease. we assessed the effect of these drugs in patients with inflammatory bowel disease (n = 209) and the possible mechanisms.